LADERA RANCH, Calif., April 10, 2012 /PRNewswire/ -- Advanced Biologics announced today that its OsteoAMP® product platform has been awarded a supplier contract with the Premier Healthcare Alliance. Effective July 1st, 2012, the agreement makes the revolutionary osteobiologic line available to Premier's 2500+ hospital members.
OsteoAMP® is an award-winning allogeneic growth factor that is a lower-cost alternative to recombinant growth factors, such as rhBMP-2 (Infuse®, Medtronic). In a recent head to head clinical study, OsteoAMP® displayed superior fusion rates to rhBMP-2 (Infuse®, Medtronic). With the recent reports of adverse events and complications related to use of rhBMP-2, it has raised many ethical, legal, and reimbursement concerns for surgeons and hospitals. OsteoAMP® represents a new category within the 'bone, tissue, synthetic implantable product' market to address such concerns and has already been used in orthopaedic/neurosurgery cases for three years without a single adverse event reported. Additionally, OsteoAMP®'s four distinctive formats (granules, compressible sponges, putty, and structural grafts) provide a distinct advantage by allowing surgeons to tailor deliver the technology according to their needs in surgery.
"We are excited to be associated with Premier Healthcare and the opportunity of offering Premier members a truly viable, cost-effective alternative to rhBMP-2," stated Amit Govil, President of Advanced Biologics. "We will continue to strive in developing products that not only meet or exceed efficacy requirements but also to ensure patient safety."
About the Premier Healthcare Alliance, Malcolm Baldrige National Quality Award recipient
Premier is a performance improvement alliance of more than 2,500 U.S. hospitals and 81,000-plus other healthcare sites using the power of collaboration to lead the transformation to high-quality, cost-effective care. Owned by hospitals, health systems and other providers, Premier maintains the nation's most comprehensive repository of clinical, financial and outcomes information and operates a leading healthcare purchasing network. A world leader in helping deliver measurable improvements in care, Premier has worked with the Centers for Medicare & Medicaid Services and the United Kingdom's National Health Service North West to improve hospital performance. Headquartered in Charlotte, N.C., Premier also has an office in Washington. https://premierinc.com
About Advanced Biologics
Founded in 2009, Advanced Biologics (ABC) is a privately-held company focused on developing innovative and clinically relevant biologic solutions across a wide degree of medical specialties. The OsteoAMP® family of osteoinductive/conductive products is the first line of orthobiologic offerings produced by ABC. ABC was awarded the Best New Regenerative Technology award in 2009, Best New Biomaterial Technology Award in 2010, and 2011 Best New Technology in Biomaterials and Biologics by the Orthopedics This Week Spine Technology Awards. Other technology platforms to follow include an allograft-derived stem cell product and a shape-memory, anti-bacterial synthetic portfolio. www.advancedbiologics.com
SOURCE Advanced Biologics, LLC.